美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

減肥藥

1,492.17

+31.152.13%

漲家數：5

跌家數：2

平家數：- -

市盈率：- -

高：1,493.70

開：1,460.44

低：1,460.44

收：1,461.02

資料載入中...

總覽新聞資訊

輝瑞中國區總裁、RDPAC執行委員會主席：對中國持續高水平對外開放深感振奮

每日经济新闻

【歐股“十一羅漢”｜諾和諾德收漲約2.5%，阿斯麥漲超1.8%，雀巢則跌超1.8%】週三，阿斯麥控股荷蘭阿姆斯特丹股價收漲1.85%，報672.70歐元。諾和諾德哥本哈根股價收漲2.48%，報631.50。德國思愛普Sap收漲2.22%，歐萊雅漲1.79%，諾華製藥漲0.62%。阿斯利康、羅氏製藥、LVMH集團、賽諾菲則收跌0.02%-0.46%，葛蘭素史克跌1.72%，雀巢跌1.83%。

德國法院裁定輝瑞和 BioNTech 侵犯了 Moderna 的 COVID-19 疫苗專利權

市場消息：德國法院裁定輝瑞(PFE.N)侵犯了莫德納的COVID-19疫苗專利。

美股異動 | 推出新平台為自費患者提供減重藥物服務諾和諾德(NVO.US)漲近4%

諾和諾德盤中異動急速上漲3.94%報90.95美元

諾和諾德對減肥藥Wegovy打折超過50%，將通過直接面對消費者的線上藥房NovoCare供應。

諾和諾德將以每月 499 美元的價格向支付現金的美國客户銷售 Wegovy

阿爾茨海默病治療費用高，禮來呼籲將靶向病因創新藥納入醫保

阿爾茨海默病治療費用高禮來呼籲將靶向病因創新藥納入醫保

深度丨諾和諾德就新藥研發失敗索賠8.3億美元轉讓方稱將抗辯

每日经济新闻

BUZZ-博雅銀行上調艾伯維開發肥胖症藥物交易的交易成本

諾和諾德盤中異動急速下跌3.01%報86.68美元

碩迪生物盤中異動早盤股價大跌5.42%

輝瑞天價併購獲得的產品，如今是賺還是虧？

Insight数据库

非洲製藥商 Aspen 稱新的拉塔姆和禮來產品組合提高了收益

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK4599/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4599"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","market":"US","secType":"PLATE","nameCN":"減肥藥","latestPrice":1492.1732,"timestamp":1741208399999,"preClose":1461.0245,"halted":0,"volume":58200771,"delay":0,"changeRate":0.02132,"change":31.148682,"pbRate":11.821485,"amount":5513579718.723701,"amplitude":0.02276,"prevYearClose":1305.0607,"fiveDayClose":1473.773,"twentyDayClose":1354.5123,"turnoverRate":0.005514,"marketCap":1606807813984,"floatMarketCap":1490733575264,"peRate":42.075031},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","high":1493.6967,"amplitude":0.02276,"preClose":1461.0245,"low":1460.4442,"pbRate":"11.821485","latestPrice":1492.1732,"volume":58200771,"delay":0,"open":1460.4442,"prevYearClose":1305.0607,"prevWeekClose":1482.1702,"prevMonthClose":1482.1702,"prevQuarterClose":1305.0607,"fiveDayClose":1473.773,"twentyDayClose":1354.5123,"sixtyDayClose":1441.3252,"secType":"PLATE","market":"US","turnoverRate":0.005514,"peRate":42.075031,"marketCap":1606807813984,"floatMarketCap":1490733575264,"timestamp":1741208399999,"nameCN":"減肥藥"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4599\",,,,undefined,":{"bkCode":"BK4599","up":5,"down":2,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4599\",pageSize:16,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2517119909","title":"輝瑞中國區總裁、RDPAC執行委員會主席：對中國持續高水平對外開放深感振奮","url":"https://stock-news.laohu8.com/highlight/detail?id=2517119909","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517119909?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 11:29","pubTimestamp":1741231789,"startTime":"0","endTime":"0","summary":"3月5日上午，第十四届全国人民代表大会第三次会议在北京人民大会堂开幕。6日，《每日经济新闻》记者获悉，辉瑞中国区总裁、RDPAC（中国外商投资企业协会药品研制和开发工作委员会）执行委员会主席Jean-ChristophePointeau聆听2025年政府工作报告后发表了感言。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202503063338330925.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202503063338330925.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1883839398.USD","BK4588","SG9999013999.USD","IE0002270589.USD","LU0170899867.USD","LU0234572021.USD","LU0306806265.USD","BK4533","BK4550","SG9999002224.SGD","LU0321505868.SGD","BK4585","SG9999001176.USD","SGXZ57979304.SGD","LU1057294990.SGD","BK4592","BK4007","LU0225771236.USD","SG9999011175.SGD","LU1066051498.USD","LU0456855351.SGD","LU0289739699.SGD","BK4599","LU0868494617.USD","LU1023059063.AUD","LU0985481810.HKD","BK4568","BK4534","LU1894683348.USD","LU0306807586.USD","LU0321505439.SGD","LU0058720904.USD","IE00B19Z3581.USD","LU0122379950.USD","LU1066053197.SGD","IE00BLSP4452.SGD","PFE","SG9999001176.SGD","IE000M9KFDE8.USD","IE00BBT3K403.USD","LU0225284248.USD","SG9999002232.USD","SG9999003800.SGD","IE00BLSP4239.USD","IE00B19Z3B42.SGD","BK4581","LU1894683264.USD"],"gpt_icon":1},{"id":"2517477049","title":"【歐股“十一羅漢”｜諾和諾德收漲約2.5%，阿斯麥漲超1.8%，雀巢則跌超1.8%】 週三，阿斯麥控股荷蘭阿姆斯特丹股價收漲1.85%，報672.70歐元。諾和諾德哥本哈根股價收漲2.48%，報631.50。德國思愛普Sap收漲2.22%，歐萊雅漲1.79%，諾華製藥漲0.62%。阿斯利康、羅氏製藥、LVMH集團、賽諾菲則收跌0.02%-0.46%，葛蘭素史克跌1.72%，雀巢跌1.83%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517477049","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517477049?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 01:53","pubTimestamp":1741197233,"startTime":"0","endTime":"0","summary":"周三，阿斯麦控股荷兰阿姆斯特丹股价收涨1.85%，报672.70欧元。诺和诺德哥本哈根股价收涨2.48%，报631.50。德国思爱普Sap收涨2.22%，欧莱雅涨1.79%，诺华制药涨0.62%。阿斯利康、罗氏制药、LVMH集团、赛诺菲则收跌0.02%-0.46%，葛兰素史克跌1.72%，雀巢跌1.83%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/06015348550800.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["IE00BJJMRZ35.SGD","LU1734074674.USD","IE00BD6J9T35.USD","LU2417539215.USD","BK4578","LU0345774631.USD","IE00BJT1NW94.SGD","LU0823434583.USD","BK4585","BK4588","LU0211331839.USD","IE0009355771.USD","AZN","BK4212","LU0345774391.USD","LU0889565916.HKD","GSK","IE0002141913.USD","IE00B2B36J28.USD","LRLCY","LU1093756168.USD","03165","LU0823434740.USD","LU2456880835.USD","BK4147","IE00B4R5TH58.HKD","IE00BZ1G4Q59.USD","GSK.UK","IE00BFTCPJ56.SGD","BK4543","BK1574","NVS","LU0154236417.USD","IE0004445239.USD","LU1093756325.SGD","LU0097036916.USD","LU2462157665.USD","NSRGY","LU0109394709.USD","NVO","BK4532","LU0320765992.SGD","01477","BK4599","BK4007","IE00BKVL7J92.USD","BK1191","BK4568","LU2236285917.USD","ASML"],"gpt_icon":0},{"id":"2517440948","title":"德國法院裁定輝瑞和 BioNTech 侵犯了 Moderna 的 COVID-19 疫苗專利權","url":"https://stock-news.laohu8.com/highlight/detail?id=2517440948","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517440948?lang=zh_tw&edition=fundamental","pubTime":"2025-03-05 22:55","pubTimestamp":1741186523,"startTime":"0","endTime":"0","summary":"德国法院裁定辉瑞和 BioNTech 侵犯了 Moderna 的 COVID-19 疫苗专利权路透社法兰克福3月5日 - 德国杜塞尔多夫一家法院周三裁定辉瑞PFE.N及其合作伙伴BioNTech22UAy.DE侵犯了ModernaMRNA.O持有的COVID-19疫苗专利。法院在一份声明中称，辉瑞公司和 BioNTech 公司必须提供使用该专利所获得收益的信息，并且他们应向 Moderna 公司作出适当赔偿，但仍可就这一裁决向上级法院提出上诉。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nL3T3PO1DW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PFE","SG9999002232.USD","LU0321505439.SGD","IE00B19Z3B42.SGD","LU0868494617.USD","SG9999011175.SGD","IE00BBT3K403.USD","BK4007","LU1057294990.SGD","SG9999001176.SGD","IE0002270589.USD","BK4592","BK4588","BK4548","BK4534","BK4585","LU0122379950.USD","LU1894683264.USD","LU1894683348.USD","BK4139","SG9999002224.SGD","BK4532","IE000M9KFDE8.USD","LU0289739699.SGD","SGXZ57979304.SGD","IE00B19Z3581.USD","IE00BLSP4239.USD","LU0225284248.USD","LU0306807586.USD","LU0170899867.USD","SG9999013999.USD","BK4551","BK4599","LU0306806265.USD","LU0456855351.SGD","LU1066051498.USD","LU0225771236.USD","BK4568","BK4581","BK4501","IE00BLSP4452.SGD","LU0234572021.USD","LU1066053197.SGD","SG9999001176.USD","SG9999003800.SGD","MRNA","LU1883839398.USD","LU1023059063.AUD","BK4533","BK4550"],"gpt_icon":0},{"id":"2517910090","title":"市場消息：德國法院裁定輝瑞(PFE.N)侵犯了莫德納的COVID-19疫苗專利。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517910090","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517910090?lang=zh_tw&edition=fundamental","pubTime":"2025-03-05 22:42","pubTimestamp":1741185745,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["LU1883839398.USD","SG9999013999.USD","BK4535","LU0868494617.USD","LU1057294990.SGD","IE00BLSP4452.SGD","LU0306807586.USD","BNTX","BK4139","BK4551","SG9999011175.SGD","LU0321505868.SGD","BK4592","BK4533","BK4548","BK4581","IE00B19Z3581.USD","LU0058720904.USD","LU0225284248.USD","159646","LU0306806265.USD","IE000M9KFDE8.USD","BK4568","LU1023059063.AUD","SG9999001176.USD","IE0002270589.USD","BK4550","IE00B19Z3B42.SGD","SG9999001176.SGD","BK4585","LU0321505439.SGD","LU0985481810.HKD","BK4534","SGXZ57979304.SGD","PFE","LU0234572021.USD","BK4599","LU1066051498.USD","IE00BLSP4239.USD","SG9999003800.SGD","BK4007","IE00BBT3K403.USD","LU0225771236.USD","LU0289739699.SGD","BK4588","SG9999002232.USD","LU0456855351.SGD","LU1066053197.SGD","LU1894683264.USD","SG9999002224.SGD"],"gpt_icon":0},{"id":"2517483129","title":"美股異動 | 推出新平台為自費患者提供減重藥物服務 諾和諾德(NVO.US)漲近4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517483129","media":"智通财经","labels":["productRelease","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517483129?lang=zh_tw&edition=fundamental","pubTime":"2025-03-05 22:38","pubTimestamp":1741185496,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周三，诺和诺德正式推出NovoCare Pharmacy，这一新平台专为自费患者提供其减重药物服务，直接挑战礼来去年推出的直销平台LillyDirect。截至发稿，诺和诺德涨近4%，报90.91美元；礼来涨超1%，报920美元。通过NovoCare，诺和诺德将为无保险患者，或虽有商业保险但不涵盖肥胖治疗的患者，提供其明星减重药物Wegovy。诺和诺德表示，患者可以通过NovoCare Pharmacy以折扣价每月499美元的现金支付方式，获得该GLP-1类减重药物，并享受送货上门服务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1258268.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["NVO","LU0154236417.USD","IE00BZ1G4Q59.USD","BK4588","BK4585","BK4532","IE00BKVL7J92.USD","BK4599","BK4007","LU1093756168.USD","LU1093756325.SGD"],"gpt_icon":0},{"id":"2517194839","title":"諾和諾德盤中異動 急速上漲3.94%報90.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517194839","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517194839?lang=zh_tw&edition=fundamental","pubTime":"2025-03-05 22:31","pubTimestamp":1741185084,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时31分，诺和诺德股票出现异动，股价大幅拉升3.94%。截至发稿，该股报90.95美元/股，成交量66.5149万股，换手率0.01%，振幅1.17%。诺和诺德股票所在的制药行业中，整体跌幅为0.20%。诺和诺德还有一个生物制药部门，专门从事血友病和其他疾病的蛋白质疗法。药物转让方称指控毫无根据。今年年初，诺和诺德便指控KBP涉嫌欺诈，隐瞒了Ocedurenone的负面临床试验数据。2025年2月28日，KBP官网发表声明称，将对诺和诺德申请获得的禁令进行抗辩。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223127abe9b08b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223127abe9b08b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BKVL7J92.USD","NVO","BK4599","BK4007","LU1093756325.SGD","BK4585","BK4588","LU0154236417.USD","IE00BZ1G4Q59.USD","BK4532","LU1093756168.USD"],"gpt_icon":1},{"id":"2517591715","title":"諾和諾德對減肥藥Wegovy打折超過50%，將通過直接面對消費者的線上藥房NovoCare供應。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517591715","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517591715?lang=zh_tw&edition=fundamental","pubTime":"2025-03-05 22:04","pubTimestamp":1741183449,"startTime":"0","endTime":"0","summary":"诺和诺德对减肥药Wegovy打折超过50%，将通过直接面对消费者的线上药房NovoCare供应。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/05220448547629.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4585","LU1093756325.SGD","LU1093756168.USD","NVO","BK4532","BK4599","LU0154236417.USD","BK4588","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","BK4007"],"gpt_icon":0},{"id":"2517914689","title":"諾和諾德將以每月 499 美元的價格向支付現金的美國客户銷售 Wegovy","url":"https://stock-news.laohu8.com/highlight/detail?id=2517914689","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517914689?lang=zh_tw&edition=fundamental","pubTime":"2025-03-05 21:30","pubTimestamp":1741181421,"startTime":"0","endTime":"0","summary":"更新版 3-更新 1-诺和诺德将以每月 499 美元的价格向支付现金的美国客户销售 Wegovy添加分析师评论、Novo 和 Hims 股份，全文脉络清晰Patrick  Wingrove/Manas Mishra. 路透社3月5日 - 诺和诺德NOVOb.CO周三表示，它将开始以每月499美元的折扣价向支付现金的患者销售减肥药Wegovy，因为它正在努力应对美国肥胖症药物市场竞争态势的变化。最低剂量每月售价 349 美元，其他剂量每月售价 499 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nL3S3PO18S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756168.USD","LU0456855351.SGD","LU0943347566.SGD","LU0094547139.USD","IE00BJJMRZ35.SGD","LU1868836914.USD","SG9999015978.USD","GB00BDT5M118.USD","IE00B1BXHZ80.USD","LU2491050071.SGD","LU2360106947.USD","SG9999015945.SGD","LU2237443622.USD","LU0417517546.SGD","IE00B4R5TH58.HKD","LU1035775433.USD","IE0002141913.USD","LU1720051017.SGD","LU2211815571.USD","LU1061106388.HKD","LU1804176565.USD","LU0198837287.USD","LU2491050154.USD","SG9999013999.USD","LU0096364046.USD","LU0238689110.USD","LU2237443549.SGD","LU2361045086.USD","LU2264538146.SGD","LU2237443382.USD","LU2602419157.SGD","IE0009355771.USD","LU1917777945.USD","LU1551013342.USD","SGXZ81514606.USD","LU2237443465.HKD","LU0203201768.USD","LU0256863902.USD","LU0006306889.USD","LU0203202063.USD","SG9999014914.USD","LU0097036916.USD","LU2023250504.SGD","LU2461242641.AUD","SG9999014898.SGD","LU0820561818.USD","SGXZ57979304.SGD","BK4599","LU2265009873.SGD"],"gpt_icon":1},{"id":"2517962076","title":"阿爾茨海默病治療費用高，禮來呼籲將靶向病因創新藥納入醫保","url":"https://stock-news.laohu8.com/highlight/detail?id=2517962076","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517962076?lang=zh_tw&edition=fundamental","pubTime":"2025-03-05 16:20","pubTimestamp":1741162821,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["IE00BK4W5L77.USD","LU1623119135.USD","SGXZ31699556.SGD","BK4588","LU1917777945.USD","SGXZ51526630.SGD","LU0122379950.USD","IE00BJJMRZ35.SGD","LU0466842654.USD","BK4516","LU1267930730.SGD","LU1023059063.AUD","LU2112291526.USD","LU2468319806.SGD","LU2237443978.SGD","159992","IE0009355771.USD","LU2237443382.USD","SG9999015986.USD","LU0094547139.USD","LU2265009873.SGD","06978","SG9999017495.SGD","IE00B1BXHZ80.USD","LU2324357040.USD","LU0006306889.USD","LLY","LU1974910355.USD","LU2023250504.SGD","LU2491049909.HKD","LU1814569148.SGD","IE00BK4W5M84.HKD","LU0097036916.USD","LU0354030438.USD","LU2361044949.HKD","GB00BDT5M118.USD","LU2237443895.HKD","LU0109391861.USD","159891","LU0820561909.HKD","LU1548497426.USD","LU0256863811.USD","LU0689472784.USD","BK4599","LU2237438978.USD","LU2491050154.USD","LU1868836591.USD","LU0289739699.SGD","SG9999018865.SGD","BK4581"],"gpt_icon":0},{"id":"2517960878","title":"阿爾茨海默病治療費用高 禮來呼籲將靶向病因創新藥納入醫保","url":"https://stock-news.laohu8.com/highlight/detail?id=2517960878","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517960878?lang=zh_tw&edition=fundamental","pubTime":"2025-03-05 16:19","pubTimestamp":1741162742,"startTime":"0","endTime":"0","summary":"【阿尔茨海默病治疗费用高 礼来呼吁将靶向病因创新药纳入医保】近日，礼来中国总裁兼总经理德赫兰在接受第一财经记者独家专访时呼吁，尽快将用于阿尔茨海默病疾病早期、靶向病因、可显著减缓疾病进程的创新药物纳入医保，提升患者的可及性和可负担性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202503053337255035.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202503053337255035.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1804176565.USD","IE0009355771.USD","SG9999015952.SGD","LU1035775433.USD","LU1093756325.SGD","LU0471298694.HKD","LU0354030438.USD","BK4007","LU0114720955.EUR","LU2357305700.SGD","SG9999014880.SGD","LU2237438978.USD","LU1064131342.USD","IE00B4R5TH58.HKD","LU1868836914.USD","LU2361044865.SGD","LU2237443622.USD","LU0466842654.USD","06978","BK4533","LU1548497426.USD","LU1868837136.USD","SG9999001176.USD","LU2265009873.SGD","LU0198837287.USD","LU2491050071.SGD","IE00BK4W5L77.USD","LU0354030511.USD","LU2264538146.SGD","IE00BJT1NW94.SGD","LU1720051017.SGD","LU1989771016.USD","SG9999015945.SGD","LU0320765059.SGD","LU0640476718.USD","LU0122379950.USD","LU2237443382.USD","LU1551013342.USD","LU2491050154.USD","BK4599","BK4585","LU0882574139.USD","LU0097036916.USD","SG9999014914.USD","IE00BFTCPJ56.SGD","LLY","LU0943347566.SGD","LU1712237335.SGD","LU2089984988.USD","SGXZ51526630.SGD"],"gpt_icon":1},{"id":"2517295793","title":"深度丨諾和諾德就新藥研發失敗索賠8.3億美元  轉讓方稱將抗辯","url":"https://stock-news.laohu8.com/highlight/detail?id=2517295793","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517295793?lang=zh_tw&edition=fundamental","pubTime":"2025-03-05 13:34","pubTimestamp":1741152853,"startTime":"0","endTime":"0","summary":"诺和诺德欲索赔8.3亿美元 药物转让方称指控毫无根据凭借GLP-1药物风生水起的诺和诺德，近期因一款新药研发失利，向原来的转让方提起诉讼。诺和诺德已经终止了该药物的三期临床试验。图片来源：诺和诺德官网截图当外界以为这是一次寻常的药物研发失利时，诺和诺德却向KBP及其创始人兼执行董事长黄振华索赔8.3亿美元。2025年2月28日，KBP官网发表声明称，将对诺和诺德申请获得的禁令进行抗辩。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305133635abe8f91c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305133635abe8f91c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4532","BK4599","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","LU1093756325.SGD","BK4007","BK4585","LU0154236417.USD","LU1093756168.USD","BK4588","NVO"],"gpt_icon":1},{"id":"2517360630","title":"BUZZ-博雅銀行上調艾伯維開發肥胖症藥物交易的交易成本","url":"https://stock-news.laohu8.com/highlight/detail?id=2517360630","media":"路透中文","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517360630?lang=zh_tw&edition=fundamental","pubTime":"2025-03-05 00:09","pubTimestamp":1741104556,"startTime":"0","endTime":"0","summary":"** 维持 \"中性 \"评级 ** 评级上调的部分 原因是ABBV本周早些时候 与丹麦生物技术公司Gubra >签署了 一项许可 ，开发一种模仿胰腺激素淀粉样蛋白的肥胖症治疗药物。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nL3T3PN1O9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0466842654.USD","LU0820561818.USD","LU0354030438.USD","LU0971096721.USD","ABBV","LU0289739699.SGD","LU1291159041.SGD","LU2237443382.USD","LU2133065610.SGD","LU1244550494.USD","LU1201861249.SGD","LU1718418525.SGD","LU2023250504.SGD","LU0097036916.USD","IE00BBT3K403.USD","LU0321505868.SGD","SG9999013999.USD","LU2461242641.AUD","LU0417517546.SGD","LU1267930730.SGD","BK4559","IE00BKVL7J92.USD","IE00BK4W5M84.HKD","LU0203345920.USD","BK4599","SGXZ99366536.SGD","LU0553294199.USD","IE00BLSP4239.USD","IE00BDGV0183.EUR","LU1791807156.HKD","SG9999015952.SGD","IE00BJT1NW94.SGD","IE0009355771.USD","GB00BDT5M118.USD","LU1093756168.USD","LU1548497426.USD","LU1267930573.SGD","LU1974910355.USD","LU0965509283.SGD","LU1244550221.USD","LU1712237335.SGD","IE00B2B36J28.USD","LU0795875169.SGD","LU0320765489.SGD","LU2491049909.HKD","SG9999014914.USD","LU2089283258.USD","LU2237438978.USD","BAC"],"gpt_icon":1},{"id":"2517606729","title":"諾和諾德盤中異動 急速下跌3.01%報86.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517606729","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517606729?lang=zh_tw&edition=fundamental","pubTime":"2025-03-05 00:08","pubTimestamp":1741104482,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日00时08分，诺和诺德股票出现异动，股价快速下挫3.01%。截至发稿，该股报86.68美元/股，成交量203.876万股，换手率0.05%，振幅2.16%。诺和诺德股票所在的制药行业中，整体跌幅为1.08%。诺和诺德公司简介：诺和诺德拥有全球约三分之一的品牌糖尿病治疗市场，是全球领先的糖尿病护理产品供应商。诺和诺德还有一个生物制药部门，专门从事血友病和其他疾病的蛋白质疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305000802a25f1efb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305000802a25f1efb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4532","BK4599","LU0154236417.USD","BK4007","BK4585","BK4588","LU1093756168.USD","LU1093756325.SGD","IE00BZ1G4Q59.USD","NVO","IE00BKVL7J92.USD"],"gpt_icon":1},{"id":"2516714608","title":"碩迪生物盤中異動 早盤股價大跌5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516714608","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516714608?lang=zh_tw&edition=fundamental","pubTime":"2025-03-04 23:19","pubTimestamp":1741101575,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日23时19分，硕迪生物股票出现波动，股价快速下挫5.42%。截至发稿，该股报21.13美元/股，成交量10.8238万股，换手率0.19%，振幅4.89%。机构评级方面，在所有12家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中，整体涨幅为0.43%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304231935a25f1345&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304231935a25f1345&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4599","BK4007","GPCR"],"gpt_icon":0},{"id":"2516612755","title":"輝瑞天價併購獲得的產品，如今是賺還是虧？","url":"https://stock-news.laohu8.com/highlight/detail?id=2516612755","media":"Insight数据库","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516612755?lang=zh_tw&edition=fundamental","pubTime":"2025-03-04 08:03","pubTimestamp":1741046636,"startTime":"0","endTime":"0","summary":"获得的管线中，哪些成了辉瑞新的增长动力？辉瑞需要通过伊曲莫德未来的表现，来体现这次收购的价值。当时已经上市的沃塞洛托，因为最新临床数据中，出现了高于预期的死亡率事件，如今已经撤市。总的来说，辉瑞通过收购成熟产品，快速补强了管线，尤其在肿瘤、偏头痛领域，都已经兑现了价值，但自免领域和血液罕见病领域，目前还处于消化期，未来给辉瑞带来多少销售增量，还需要时间来验证。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304135745abe74147&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304135745abe74147&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4550","SG9999003800.SGD","BK4581","LU1894683348.USD","BK4588","LU0225771236.USD","BK4533","LU0868494617.USD","SG9999013999.USD","LU0058720904.USD","LU1894683264.USD","SG9999001176.USD","IE00BLSP4452.SGD","LU0234572021.USD","LU0321505439.SGD","LU0289739699.SGD","SG9999001176.SGD","BK4007","IE00B19Z3B42.SGD","IE0002270589.USD","LU0321505868.SGD","LU1066053197.SGD","IE00B19Z3581.USD","BK4568","BK4534","LU0306807586.USD","IE00BLSP4239.USD","LU1023059063.AUD","LU1883839398.USD","SG9999002224.SGD","LU0170899867.USD","BK4585","LU0122379950.USD","BK4592","SGXZ57979304.SGD","LU1057294990.SGD","BK4599","LU0985481810.HKD","LU0306806265.USD","PFE","IE000M9KFDE8.USD","LU0456855351.SGD","LU1066051498.USD","SG9999002232.USD","SG9999011175.SGD","IE00BBT3K403.USD","LU0225284248.USD"],"gpt_icon":1},{"id":"2516656979","title":"非洲製藥商 Aspen 稱新的拉塔姆和禮來產品組合提高了收益","url":"https://stock-news.laohu8.com/highlight/detail?id=2516656979","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516656979?lang=zh_tw&edition=fundamental","pubTime":"2025-03-04 01:10","pubTimestamp":1741021857,"startTime":"0","endTime":"0","summary":"更新版 1-更新 1-非洲制药商 Aspen 称新的拉塔姆和礼来产品组合提高了收益添加 GLP-1 药物详情和首席执行官对 Mounjaro 的全程评论Nqobile Dludla路透社约翰内斯堡3月3日 - Aspen Pharmacare APNJ.J周一公布的半年盈利增长了5%，并表示受益于拉丁美洲的产品组合和减肥药Mounjaro的推出，预计全年其商业制药部门的收入和核心利润将有两位数的增长。这家总部位于南非的制药公司正在大力争取一类名为 GLP-1 类似物的药物合同，用于治疗糖尿病和减肥。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250303:nL3S3PM1AV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0079474960.USD","LU0122379950.USD","LU1061106388.HKD","LU2023250504.SGD","SG9999015952.SGD","LU1989771016.USD","SG9999015945.SGD","LU1868836914.USD","LU0061475181.USD","LU0354030511.USD","SG9999017495.SGD","VTRS","BK4599","BK4007","LLY","LU0354030438.USD","SGXZ57979304.SGD","SGXZ51526630.SGD","IE00B4R5TH58.HKD","LU0820561909.HKD","LU2237443622.USD","LU1366192091.USD","LU1551013342.USD","LU2237443465.HKD","SG9999015986.USD","LU0882574139.USD","LU1804176565.USD","SG9999014880.SGD","LU1814569148.SGD","LU1023059063.AUD","BK4534","LU2468319806.SGD","LU2357305700.SGD","IE00BJJMRZ35.SGD","IE00B1BXHZ80.USD","LU1093756168.USD","IE00BK4W5L77.USD","IE0009355771.USD","LU2491050071.SGD","IE00BJT1NW94.SGD","LU1988902786.USD","LU0820561818.USD","IE00BFTCPJ56.SGD","LU0289739699.SGD","LU1983299246.USD","LU2265009873.SGD","SGXZ81514606.USD","LU2602419157.SGD","LU2361044865.SGD","LU0256863902.USD"],"gpt_icon":1}],"pageSize":16,"totalPage":8,"pageCount":1,"totalSize":114}]}}